The human G93A SOD1 phenotype closely resembles sporadic amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 7, 2010, Pages 764-767

  Synofzik, Matthis ^a   Fernández Santiago, Rubén ^a,b   Maetzler, Walter ^a   Schöls, Ludger ^a   Andersen, Peter M ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; MALE; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; ONSET AGE; PATHOGENESIS; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RODENT; TRANSGENIC MOUSE; ADOLESCENT; AGED; CHILD; ELECTROPHYSIOLOGY; ENZYMOLOGY; GENETICS; GERMANY; HETEROZYGOTE; INFANT; MIDDLE AGED; MUTATION; PATHOLOGY; PEDIGREE; PHYSIOLOGY; PRESCHOOL CHILD;

COPPER ZINC SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CHILD; CHILD, PRESCHOOL; ELECTROPHYSIOLOGY; FEMALE; GERMANY; HETEROZYGOTE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; SUPEROXIDE DISMUTASE;

EID: 77954665543     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.181719     Document Type: Article

References (16)

1. Gurney ME. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci 1997;152(Suppl 1):S67-73.
2. Turner BJ, Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 2008;85:94-134.
3. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772-5.
4. Andersen PM, Sims KB, Xin WW, et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:62-73.
5. Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 2006;6:37-46. (Pubitemid 43154251)
6. Schnabel J. Neuroscience: standard model. Nature 2008;454:682-5.
7. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65(Suppl 1):S3-9.
8. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62. (Pubitemid 23087289)
9. Nogales-Gadea G, Garcia-Arumi E, Andreu AL, et al. A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. J Neurol Sci 2004;219:1-6. (Pubitemid 38405990)
10. Penco S, Schenone A, Bordo D, et al. A SOD1 gene mutation in a patient with slowly progressing familial ALS. Neurology 1999;53:404-6. (Pubitemid 29344368)
11. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
12. Kalbe E, Kessler J, Calabrese P, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004;19:136-43. (Pubitemid 38247848)
13. Andersen PM, Borasio GD, Dengler R, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 2007;8:195-213.
14. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118(Pt 3):707-19.
15. Ringholz GM, Appel SH, Bradshaw M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586-90. (Pubitemid 41170719)
16. Sgobio C, Trabalza A, Spalloni A, et al. Abnormal medial prefrontal cortex connectivity and defective fear extinction in the presymptomatic G93A SOD1 mouse model of ALS. Genes Brain Behav 2008;7:427-34. (Pubitemid 351590929)